SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006864
Filing Date
2021-05-12
Accepted
2021-05-12 07:36:00
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20210331x10q.htm 10-Q 942360
2 EX-31.1 hook-20210331ex311a25a44.htm EX-31.1 9852
3 EX-31.2 hook-20210331ex3127084e0.htm EX-31.2 9831
4 EX-32.1 hook-20210331ex321d35b3f.htm EX-32.1 8319
  Complete submission text file 0001558370-21-006864.txt   4627332

Data Files

Seq Description Document Type Size
5 EX-101.INS hook-20210331.xml EX-101.INS 825976
6 EX-101.SCH hook-20210331.xsd EX-101.SCH 49105
7 EX-101.CAL hook-20210331_cal.xml EX-101.CAL 45640
8 EX-101.DEF hook-20210331_def.xml EX-101.DEF 173081
9 EX-101.LAB hook-20210331_lab.xml EX-101.LAB 433721
10 EX-101.PRE hook-20210331_pre.xml EX-101.PRE 313160
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 21913464
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences